Elite Pharmaceuticals, Inc.

The current price of ELTP is 0.1300 USD — it has decreased by 2.62% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Elite Pharmaceuticals, Inc. stocks are traded under the ticker ELTP.

Elite Pharmaceuticals, Inc. is going to release the next earnings report on Jun 12, 2024. Keep track of upcoming events with our Earnings Calendar.

ELTP stock is 4.69% volatile and has beta coefficient of −1.23. Check out the list of the most volatile stocks — is Elite Pharmaceuticals, Inc. there?

Yes, you can track Elite Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

ELTP stock has fallen by 7.14% compared to the previous week, the month change is a 8.64% fall, over the last year Elite Pharmaceuticals, Inc. has showed a 319.35% increase.

Today Elite Pharmaceuticals, Inc. has the market capitalization of ‪135.87 M‬, it has decreased by 9.31% over the last week.

No, ELTP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, ELTP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Elite Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

ELTP reached its all-time high on Mar 7, 2000 with the price of 24.5000 USD, and its all-time low was 0.0230 USD and was reached on Dec 6, 2021.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 53.00 employees. See our rating of the largest employees — is Elite Pharmaceuticals, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Elite Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Elite Pharmaceuticals, Inc. stock shows the buy signal. See more of Elite Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Elite Pharmaceuticals, Inc. EBITDA is ‪8.32 M‬ USD, and current EBITDA margin is 15.52%. See more stats in Elite Pharmaceuticals, Inc. financial statements.